As Arab Spring Stabilizes, Hikma Sees Improved Results And Better Position
This article was originally published in PharmAsia News
Executive Summary
For a company like Hikma Pharmaceuticals PLC with over half of its business operating in the Middle East and North Africa, the first half of 2011 has been a challenging time. The political instability in many countries, especially in Egypt and Tunisia, has hurt Hikma's growth and profitability in the first six months